Adma Biologics (ADMA) Net Margin (2011 - 2025)
Adma Biologics (ADMA) posted Net Margin of 95.77% for Q4 2025, down 452.88% on a QoQ basis from 27.14% in Q3 2025, and down 13819.0% year-over-year from N/an in Q4 2024.
Adma Biologics (ADMA) Net Margin (2011 - 2025) Analysis & Trends
Adma Biologics' Net Margin history runs 13 years deep, the most recent figure standing at 95.77% for Q4 2025.
- Quarterly Net Margin fell 13819.0% year-over-year to 95.77% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 7.0% (down 3881.0% YoY) and the FY2025 annual result came in at 7.0%, down 3881.0% from the prior year.
- Net Margin was 95.77% for Q4 2025 at Adma Biologics, down from 27.14% in the prior quarter.
- Across five years, Net Margin topped out at 42.42% in Q4 2024 and bottomed at 114.26% in Q1 2021.
- A 5-year average of 20.23% and a median of 11.26% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2021 — Net Margin jumped 15346 bps — and 2025, when it tumbled 13819 bps.
- Adma Biologics' Net Margin stood at 45.72% in 2021, then climbed by 18 bps to 37.29% in 2022, then soared by 138 bps to 14.33% in 2023, then surged by 196 bps to 42.42% in 2024, then sank by 326 bps to 95.77% in 2025.
- Business Quant data shows ADMA's Net Margin at 95.77% in Q4 2025, 27.14% in Q3 2025, and 28.05% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | -95.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -95.77% |
| Sep 30, 2025 | 27.14% |
| Jun 30, 2025 | 28.05% |
| Mar 31, 2025 | 23.44% |
| Dec 31, 2024 | 42.42% |
| Sep 30, 2024 | 29.96% |
| Jun 30, 2024 | 29.91% |
| Mar 31, 2024 | 21.75% |
| Dec 31, 2023 | 14.33% |
| Sep 30, 2023 | 2.33% |
| Jun 30, 2023 | -10.60% |
| Mar 31, 2023 | -11.93% |
| Dec 31, 2022 | -37.29% |
| Sep 30, 2022 | -36.24% |
| Jun 30, 2022 | -18.33% |
| Mar 31, 2022 | -62.44% |
| Dec 31, 2021 | -45.72% |
| Sep 30, 2021 | -85.74% |
| Jun 30, 2021 | -105.56% |
| Mar 31, 2021 | -114.26% |